marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2023-Q1
added 05-15-2023
Sorrento Therapeutics Financial Ratios 2011-2024 | SRNE
Annual Financial Ratios Sorrento Therapeutics
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.4 | -9.7 | -1.8 | -1.1 | 56.9 | -4.3 | -4.2 | -7.8 | -6.9 | -14.7 | -16.9 |
P/S |
-4679.0 | 72.8 | 16.4 | 10.9 | 3.4 | 32.4 | 42.2 | 70.4 | 329.3 | 122.1 | 103.1 |
EPS |
-1.4 | -1.3 | -2.2 | -1.9 | 0.1 | -1.2 | -1.2 | -1.3 | -1.5 | -0.0 | -0.0 |
EV (Enterprise Value) |
1.17 B | 3.25 B | 1.02 B | 488 M | 724 M | 497 M | 357 M | 230 M | 146 M | 66.8 M | 51.5 M |
EBITDA per Share |
-1.32 | -0.859 | -1.44 | -1.19 | 0.775 | -1.17 | -1.32 | -1.21 | -0.989 | -0.4 | -0.311 |
EV/EBITDA |
-3.0 | -15.0 | -3.8 | -2.4 | 9.3 | -3.9 | -3.4 | -6.5 | -8.4 | -14.5 | -16.6 |
PEG |
0.02 | -0.24 | 0.12 | 0.0 | 0.51 | -1.79 | -0.92 | -0.71 | 0.04 | 0.15 | 0.57 |
P/B |
7.5 | 17.6 | 6.6 | 1.1 | 2.6 | 3.3 | 1.3 | 2.5 | 2.3 | 11.5 | 13.0 |
P/CF |
-2.1 | -14.8 | -2.8 | -1.9 | -4.7 | -3.4 | -4.2 | -9.2 | -8.7 | -16.4 | -14.4 |
ROE % |
-543.92 | -180.72 | -371.64 | -97.17 | 4.58 | -76.12 | -31.56 | -31.88 | -32.80 | -78.18 | -76.89 |
ROA % |
-61.65 | -55.70 | -52.38 | -32.61 | 2.12 | -15.17 | -13.34 | -24.49 | -23.67 | -71.45 | -70.84 |
ROCE % |
-509.79 | -45.87 | -44.12 | -23.02 | 14.59 | -18.40 | -15.99 | -26.16 | -18.00 | -78.30 | -77.03 |
Current Ratio |
1.1 | 0.9 | 0.6 | 2.9 | 0.4 | 1.2 | 4.6 | 7.7 | 6.0 | 9.0 | 9.9 |
DSO |
-49566.1 | 141.5 | 168.5 | 75.1 | 9.4 | 133.7 | 208.2 | 69.9 | 312.7 | 49.9 | 42.2 |
DIO |
- | 67.2 | 100.3 | - | - | - | - | - | - | - | - |
DPO |
- | 907.2 | 824.1 | 714.3 | 917.0 | 3727.4 | 250.6 | 295.9 | 177064.5 | - | - |
Operating Cycle |
-49566.1 | 208.8 | 268.8 | 75.1 | 9.4 | 133.7 | 208.2 | 69.9 | 312.7 | - | - |
Cash Conversion Cycle |
-49566.1 | -698.4 | -555.3 | -639.3 | -907.6 | -3593.8 | -42.4 | -226.0 | -176751.7 | - | - |
All numbers in USD currency
Quarterly Financial Ratios Sorrento Therapeutics
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.26 | - | -0.2 | -0.54 | -0.12 | -0.47 | -0.4 | -0.57 | 0.01 | -0.27 | -0.33 | -0.36 | -0.36 | -0.41 | -0.49 | -0.46 | -0.88 | -0.41 | -0.4 | -0.73 | -0.38 | 0.6 | -0.03 | -0.2 | -0.45 | -0.3 | 0.24 | -0.93 | -0.41 | -0.62 | -0.03 | -0.3 | -0.29 | -0.26 | -0.27 | -0.33 | -0.44 | - | -0.24 | -0.35 | -0.2 | - | -0.1 | -0.08 | - | - | - | - | - |
EBITDA per Share |
-0.19 | - | -0.22 | -0.28 | -0.31 | - | -0.31 | -0.33 | -0.29 | - | -0.3 | -0.19 | -0.22 | - | -0.34 | -0.36 | -0.98 | - | -0.36 | -0.24 | -0.36 | - | 1.33 | -0.15 | -0.43 | - | -0.17 | -0.94 | -0.57 | - | -905 | -0.25 | -0.26 | - | -0.17 | -254 | -395 | - | -0.19 | -0.33 | -0.2 | - | -0.09 | -0.07 | - | - | - | - | - |
ROE % |
-186.29 | -247.65 | -431.04 | -454.32 | -382.51 | -363.42 | -223.32 | -182.97 | -140.20 | -180.72 | -217.36 | -248.45 | -273.60 | -371.64 | -315.47 | -256.10 | -219.13 | -97.17 | -49.13 | -27.57 | 0.58 | 4.58 | -42.01 | -21.12 | -68.12 | -76.12 | -72.13 | -92.63 | -46.07 | -33.71 | -23.21 | -29.56 | -29.79 | -31.88 | -29.08 | -27.11 | -52.13 | -70.62 | -148.80 | -221.96 | -267.34 | -170.99 | -187.67 | -126.17 | -73.83 | -58.78 | -16.68 | -25.84 | -16.26 |
ROA % |
-94.17 | -54.04 | -74.83 | -76.19 | -62.87 | -57.71 | -50.27 | -50.03 | -43.14 | -55.70 | -53.62 | -49.49 | -45.16 | -52.38 | -49.09 | -45.12 | -46.77 | -32.61 | -13.41 | -6.31 | 2.24 | 2.12 | -13.56 | -9.12 | -16.62 | -15.17 | -18.47 | -22.70 | -15.10 | -14.24 | -12.51 | -17.61 | -20.39 | -24.49 | -22.10 | -20.35 | -38.05 | -50.96 | -122.41 | -190.23 | -238.01 | -156.26 | -171.63 | -115.55 | -67.91 | -54.16 | -15.37 | -23.81 | -14.98 |
ROCE % |
-168.46 | -217.44 | -294.64 | -288.84 | -255.85 | -168.17 | -218.49 | -191.61 | -166.31 | -105.36 | -173.16 | -190.64 | -225.82 | -288.61 | -311.48 | -266.55 | -216.01 | -51.95 | -3.39 | 68.05 | 74.85 | 30.13 | 14.83 | -49.04 | -98.16 | -98.67 | -123.22 | -132.47 | -83.86 | -38.82 | -45.38 | -27.39 | -27.48 | -22.99 | -27.94 | -26.33 | -26.04 | -15.77 | -35.84 | -50.95 | -59.13 | -49.95 | -66.67 | -63.32 | -73.96 | -58.89 | -16.72 | -25.88 | -16.30 |
Current Ratio |
0.8 | 1.0 | 1.3 | 1.3 | 1.4 | 1.1 | 1.2 | 1.3 | 1.6 | 1.4 | 1.4 | 1.4 | 1.4 | 1.1 | 1.1 | 1.1 | 1.1 | 1.5 | 1.5 | 1.5 | 1.5 | 1.9 | 1.9 | 1.9 | 1.9 | 1.3 | 1.3 | 1.3 | 1.3 | 1.7 | 1.7 | 1.7 | 1.7 | 4.3 | 4.3 | 4.3 | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
143.2 | - | 35988.6 | 31296.8 | 107.7 | 122.7 | 10819.5 | -80353.9 | -3464.3 | 123.0 | -2499.9 | -301.1 | -2458.5 | 91.1 | 168.6 | 121.1 | 83.5 | 40.2 | 67.9 | 89.4 | 44.1 | 9.9 | 1.6 | 43.2 | 36.6 | 38.5 | 69.0 | 171.6 | 120.0 | 61.6 | 74.7 | 70.2 | 76.3 | 83.7 | 52.4 | 86.2 | 52.6 | - | 433.2 | 253.2 | 161.3 | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 93.5 | 123.8 | - | 121.5 | 215.7 | 100.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 768.4 | 819.3 | - | 579.1 | 1028.4 | 825.8 | - | 833.5 | 1108.3 | 780.1 | - | 1808.0 | 2561.8 | 1222.7 | - | 202.3 | 389.1 | 268.5 | - | 286.7 | 296.3 | 308.7 | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
143.2 | - | 35988.6 | 31296.8 | 107.7 | 122.7 | 10819.5 | -80353.9 | -3464.3 | 123.0 | -2499.9 | -301.1 | -2458.5 | 91.1 | 168.6 | 214.6 | 207.2 | 40.2 | 189.4 | 305.1 | 145.0 | 9.9 | 1.6 | 43.2 | 36.6 | 38.5 | 69.0 | 171.6 | 120.0 | 61.6 | 74.7 | 70.2 | 76.3 | 83.7 | 52.4 | 86.2 | 52.6 | - | 433.2 | 253.2 | 161.3 | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
143.2 | - | 35988.6 | 31296.8 | 107.7 | 122.7 | 10819.5 | -80353.9 | -3464.3 | 123.0 | -2499.9 | -301.1 | -2458.5 | 91.1 | 168.6 | -553.8 | -612.1 | 40.2 | -389.8 | -723.3 | -680.8 | 9.9 | -831.9 | -1065.1 | -743.6 | 38.5 | -1739.0 | -2390.2 | -1102.7 | 61.6 | -127.6 | -318.9 | -192.1 | 83.7 | -234.4 | -210.1 | -256.0 | - | 433.2 | 253.2 | 161.3 | - | - | - | - | - | - | - | - |
All numbers in USD currency